AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Silk Road MedicalInovio PharmaceuticalsShockwave MedicalAtrionAtriCure
SymbolNASDAQ:SILKNASDAQ:INONASDAQ:SWAVNASDAQ:ATRINASDAQ:ATRC
Price Information
Current Price$38.21$14.75$43.60$642.00$47.81
52 Week RangeBuyBuyBuyN/ABuy
Beat the Market™ Rank
Overall Score1.51.21.31.31.4
Analysis Score3.52.42.30.02.4
Community Score2.43.12.42.32.9
Dividend Score0.00.00.03.30.0
Ownership Score1.00.01.01.01.0
Earnings & Valuation Score0.60.60.60.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/ABuy
Consensus Price Target$49.67$12.33$42.57N/A$46.22
% Upside from Price Target29.98% upside-16.38% downside-2.36% downsideN/A-3.32% downside
Trade Information
Market Cap$1.24 billion$2.09 billion$1.39 billion$1.21 billion$1.96 billion
BetaN/A1.340.790.160.78
Average Volume423,91630,051,404456,4517,335481,521
Sales & Book Value
Annual Revenue$63.35 million$4.11 million$42.93 million$155.07 million$230.81 million
Price / Sales18.98567.3932.367.618.30
CashflowN/AN/AN/A$24.96 per shareN/A
Price / CashN/AN/AN/A25.72N/A
Book Value$2.03 per share$1.19 per share$5.58 per share$127.93 per share$5.67 per share
Price / Book18.8212.397.815.028.43
Profitability
Net Income$-52,420,000.00$-119,360,000.00$-51,110,000.00$36.76 million$-35,190,000.00
EPS($1.36)($1.16)($2.14)N/A($1.07)
Trailing P/E RatioN/AN/AN/A33.01N/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-54.94%-4,700.42%-112.25%23.06%-19.98%
Return on Equity (ROE)-44.17%-166.85%-38.18%15.57%-19.19%
Return on Assets (ROA)-24.11%-59.66%-30.97%14.09%-9.40%
Dividend
Annual PayoutN/AN/AN/A$6.20N/A
Dividend YieldN/AN/AN/A0.97%N/A
Three-Year Dividend GrowthN/AN/AN/A11.27%N/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/A17 YearsN/A
Debt
Debt-to-Equity Ratio0.70%0.51%0.14%N/A0.32%
Current Ratio8.40%8.53%10.53%9.88%3.25%
Quick Ratio7.56%8.53%9.68%6.70%2.43%
Ownership Information
Institutional Ownership Percentage98.07%27.83%78.93%65.65%89.93%
Insider Ownership PercentageN/A4.00%15.30%22.44%5.80%
Miscellaneous
Employees176281162570620
Shares Outstanding31.47 million158.10 million31.86 million1.84 million40.07 million
Next Earnings Date8/3/2020 (Estimated)8/13/2020 (Estimated)8/3/2020 (Estimated)8/5/2020 (Estimated)8/4/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.